Culturally Adapted Cognitive Behavioral Therapy for Prevention of Self Harm

NCT01308151 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2013-12-17

No results posted yet for this study

Summary

Aim:

To adapt and develop a culturally appropriate psychological intervention and test its feasibility, and acceptability for the patients presenting to general hospital following self-harm in Karachi Pakistan.

Primary hypothesis:

Patients who receive cognitive behavioral therapy will show significant decrease in suicidal ideation as compared to patients with treatment as usual.

Design:

Randomized Control Trial

Setting:

Medical Departments of General Hospitals in Karachi.

Participants:

A total of 200 self harm patients will be randomized to psychological intervention and treatment as usual arm.

Intervention:

Culturally Adapted Cognitive Behavioral Therapy (CBT)

Outcome measure:

Beck Suicidal Ideation Scale

Conditions

Interventions

OTHER

Other

No interventions other than the culturally adapted manualised cognitive behavioral therapy

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER
  • Dow University of Health Sciences

    collaborator OTHER
  • Abbasi Shaheed Hospital

    collaborator OTHER
  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nusrat Husain, MD · Pakistan Institute of Learning and Living, University of Manchester

  • Nasim Chaudhry, MRCPsych, MD · University of Manchester

  • Imran Chaudhry, MD · University of Manchester

  • Salahuddin Afsar, FRCP · Dow University of Health Sciences Karachi

  • Meher Husain, MD · Pakistan Institute of Living and Learning

  • Raza Ur-Rehman, FCPS · Dow University of Health Sciences

  • Batool Fatima · Pakistan Institute of Living and Learning

  • Farooq Naeem, MRCPsych · Pakistan Institute of Learning and Living, University of Southampton

  • Munir Hamirani, FCPS · Abbasi Shaheed Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-03-31
Completion
2012-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308151 on ClinicalTrials.gov